The R21/Matrix-M malaria vaccine, administered in four doses at 6, 7, 8 and 18 months, will initially target 1.1 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback